-37.7%
HIMS vs MRNA
+945.0%
-982.7%
-66.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.7% | +13.1% | -9.4% | +2.1% |
| 7D | -9.1% | +20.6% | -29.7% | -11.2% |
| 30D | -10.1% | +27.1% | -37.3% | -13.1% |
| 3M | -17.1% | +353.4% | -370.5% | -38.9% |
| 6M | -2.2% | +446.3% | -448.5% | -33.6% |
| YTD | -17.9% | +776.2% | -794.1% | -50.3% |
| 1Y | -37.7% | +987.9% | -1,025.6% | -66.6% |
| All | -37.7% | +945.0% | -982.7% | -66.6% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling